Health Trials

About this trial

This is a prospective, randomized-controlled trial that assesses the efficacy of a brief Acceptance and Commitment Therapy (ACT-i), compared to an attentional control group, in adults with chronic insomnia. The interventions will be evaluated for their impact on insomnia severity, cognitive function, depression, anxiety, psychological flexibility, and sleep beliefs - measured before treatment, two weeks after and at a three-month follow-up.

Eligibility criteria

Qualifiers

clinical/ subclinical diagnosis of chronic insomnia either already diagnosed by a professional, or identified with SCISD-R by our team of clinicians

age over 18 and older, but not over 59 years old;

minimal/ mild symptomatology of depression (scores ≤ 9 on PHQ-9) and/ or anxiety (scores ≤ 9 on GAD-7) or as diagnosed with SCID-5-CV;

Disqualifiers

diagnosed with a neurological degenerative disorder, or any moderate/ severe psychiatric disorder;

diagnosed with other sleep disorder (e.g., sleep apnea, restless legs/ periodic limb movements, circadian-based sleep disorder);

diagnosed with cognitive impairments;

unable to understand Romanian;

Trial design

Treatments tested in this trial

  • Acceptance and Commitment Therapy for Insomnia
  • Attentional Control Group

Treatment groups

76 Participants
are divided into 2 treatment groups

Locations

1
Babes Bolyai University Cluj-Napoca Romania

Sponsors and collaborators

Babes-Bolyai University

Lead sponsor

Source ClinicalTrials.gov